Nigel Fry

Nigel Fry currently serves as the Chief Executive Officer of Schauenburg Analytics Ltd, overseeing the Schauenburg Analytics Group, including Markes International and Sepsolve Analytics, since September 2023. Prior experience includes roles as Managing Director and VP for EMEA & Asia at Antylia Scientific from February 2020 to September 2023 and General Manager for the Whatman business at GE Healthcare, where significant business turnaround was achieved. Nigel Fry has also held various leadership positions at GE Healthcare, including Director of Product Management for Cell Therapy and Integration Leader for GE Life Sciences, as well as roles at Wolfson Molecular Imaging Centre, AstraZeneca PLC, and ICI PLC. Educational qualifications include an MBA with Distinction from Alliance Manchester Business School and a First-Class MEng degree in Chemical Engineering with Management and German from the University of Birmingham.